Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01963091 · ClinicalTrials.gov registry record · Phase 2
Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT01963091 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 33 participants.
The verdict
NCT01963091, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
Stress is associated with drug craving and relapse in substance-dependent individuals. Hormones released from the brain may mediate the behavioral response to stress. For example, several studies have indicated that oxytocin reduces stress in laboratory stress paradigms. Specifically, it appears that oxytocin promotes trust, social interaction, and calmness; yet, little is known about the potential affects of oxytocin in cocaine-dependent individuals. Given these properties of oxytocin, it may have a therapeutic role in ameliorating the negative affect commonly observed prior to relapse in cocaine-dependent individuals, as well as the anxiety associated with withdrawal. This pilot protocol will provide important preliminary data on the effect of oxytocin on stress in cocaine-dependent individuals.
Interventions
- DRUG saline
- DRUG oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01963091
The ClinicalTrials.gov registry entry for NCT01963091 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT01963091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01963091 about?
NCT01963091 is a clinical study titled "Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals". Stress is associated with drug craving and relapse in substance-dependent individuals. Hormones released from the brain may mediate the behavioral response to stress. For example, several studies have indicated that oxytocin reduces stress in laboratory stress paradigms. Specifically, it appears tha...
What is the current status of trial NCT01963091?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2011-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01963091?
The interventions under investigation include: saline (DRUG), oxytocin (DRUG).
Who is sponsoring clinical trial NCT01963091?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.